Literature DB >> 8924751

Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome.

D S Goldstein1, A McRae, C Holmes, M C Dalakas.   

Abstract

We report here the case of a patient with the Shy-Drager syndrome and multiple myeloma who had evidence consistent with a central neural autoimmune basis for sympathetic autonomic failure. Autonomic function testing showed no recordable peroneal skeletal muscle sympathoneural traffic, normal arterial norepinephrine (NE) spillover during supine rest and no increment in NE spillover during exposure to lower body negative pressure. The patient's cerebrospinal fluid and serum contained an immunoglobulin G that bound to rat locus ceruleus (LC) in an in vitro test system. The myeloma protein was of the lambda subtype and bound in the rat LC, without binding in the substantia nigra, as demonstrated with anti-lambda antiserum. Since in this case the monoclonal antibody produced by the myeloma bound specifically to LC cells, the results are consistent with the hypothesis that in this patient the Shy-Drager syndrome may have had an immune-mediated basis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924751     DOI: 10.1007/bf02291401

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  16 in total

1.  Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure.

Authors:  I T Meredith; G Eisenhofer; G W Lambert; G L Jennings; J Thompson; M D Esler
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

2.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system.

Authors:  S Y Shu; G Ju; L Z Fan
Journal:  Neurosci Lett       Date:  1988-02-29       Impact factor: 3.046

4.  Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopamine-mice and rats-immunosympathectomy-chemical sympathectomy-superior cervical ganglion).

Authors:  P U Angeletti; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

5.  Neuronal antibodies and autonomic failure.

Authors:  W Murphy; R Mann; B P McGrath; C Bell
Journal:  Lancet       Date:  1993-08-28       Impact factor: 79.321

6.  Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.

Authors:  C Holmes; G Eisenhofer; D S Goldstein
Journal:  J Chromatogr B Biomed Appl       Date:  1994-03-04

Review 7.  Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure.

Authors:  I Biaggioni; R M Robertson; D Robertson
Journal:  J Clin Pharmacol       Date:  1994-05       Impact factor: 3.126

8.  Sympathetic reactivity during a yohimbine challenge test in essential hypertension.

Authors:  D S Goldstein; E Grossman; S Listwak; C J Folio
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

9.  Antibody in the CSF of patients with multiple system atrophy reacts specifically with rat locus ceruleus.

Authors:  R J Polinsky; A McRae; S M Baser; A Dahlström
Journal:  J Neurol Sci       Date:  1991-11       Impact factor: 3.181

10.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  3 in total

1.  Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure.

Authors:  Richard Imrich; David S Goldstein; David M Jacobowitz
Journal:  Clin Auton Res       Date:  2006-09-14       Impact factor: 4.435

2.  Dysautonomic polyneuropathy as a variant of chronic inflammatory "demyelinating" polyneuropathy?

Authors:  Hans-Heinrich Wolf; Malte Erich Kornhuber; Joachim Weis; Andreas Posa
Journal:  Clin Auton Res       Date:  2016-07-05       Impact factor: 4.435

3.  Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy.

Authors:  Yoshiki Nakae; Mizuki Hyuga; Yuta Terada; Wataru Kishimoto; Akiko Fukunaga; Sumie Tabata; Yoshitomo Maesako; Kenichi Komatsu; Osamu Higuchi; Toshinari Nakane; Nobuyoshi Arima
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.